Down syndrome immune woes traced to unexpected culprit, study finds
New research identifies an underlying cause of severe immune responses in Down syndrome, explaining why mild infections can turn dangerous.
Medicine & Biotech
Clinical AI, drug discovery, devices, and regulatory approvals.
La Trobe study finds persistent gaps in HIV testing and prevention
A new La Trobe University report shows that despite treatment advances, some people remain vulnerable because of uneven access to testing and prevention.
Malaria elimination needs layered tools, not a single fix
A new review argues that rising malaria cases and drug resistance demand a portfolio of interventions, not one magic solution.
Early Deafness Rewires Brain for Wider Peripheral Vision
A new study shows that people deaf from an early age develop enhanced peripheral vision, a neural adaptation that may act as a built-in danger detector.
Opinion: RN Experience Should Precede NP Training
A MedPage Today opinion piece argues that nurse practitioner education should require prior registered nurse work experience to protect the profession's integrity.
Argentina's Record Suicide Rates Spur Calls for Open Dialogue
As suicide numbers hit historic highs in Argentina, relatives and mental health experts are urging public conversation to address the crisis.
Florida Reports Dengue Death Amid One of Its Worst Outbreaks
A confirmed fatality marks a new milestone in Florida's severe dengue surge, underscoring the outbreak's growing toll.
Jehovah's Witnesses Ease Ban on Some Blood-Derived Products
The religious group now permits certain blood-derived medical products while maintaining its prohibition on whole-blood transfusions.
New Weekly Tracker to Follow Oral GLP-1 Prescription Race
Fierce Pharma launches a weekly data-driven tracker to monitor how Novo Nordisk's Wegovy pill and Eli Lilly's Foundayo compete for the oral weight-loss market.
FDA Approves Bayer's Kerendia for Type 1 Diabetes Kidney Disease
The approval marks the first new treatment in 30 years for chronic kidney disease associated with type 1 diabetes.
Sling raises $123M to test oral thyroid eye disease drug in phase 3
The funding will push an oral rival to the infused treatment Tepezza through late-stage trials and toward market entry.
Roche's Lunsumio Meets Primary Endpoint in Earlier-Line Follicular Lymphoma
A confirmatory phase 3 trial showed Roche's T-cell engager Lunsumio achieved its primary endpoint in earlier-line follicular lymphoma.
FDA Warns Bausch & Lomb Over Tampa Eye-Med Plant Contamination
The FDA has issued a warning letter to Bausch & Lomb over contamination concerns at its Tampa, Florida, facility that makes prescription and over-the-counter eye medications.
Agentic AI Points to New Automation Era for Clinical Trials
A sponsored Fierce Pharma analysis says agentic AI could tie together fragmented clinical trial workflows and accelerate execution.
Bavarian Nordic names Sanofi, AstraZeneca veteran as next CEO
The Danish vaccine maker is turning to a pharma industry veteran to succeed longtime CEO Paul Chaplin.
Enhertu Wins NICE Backing for HER2-Low Breast Cancer After 2024 Rejection
England and Wales' drug value assessor now deems AstraZeneca and Daiichi Sankyo's antibody drug conjugate cost-effective for NHS use in advanced HER2-low breast cancer.
EU Panel Backs Novo Hemophilia A Drug and AZ Offerings
Europe's drug advisory body issued positive opinions for a batch of medicines, including a next-generation hemophilia A therapy from Novo Nordisk and new products from AstraZeneca.
Damon Wayans uses comedy for Genentech DME awareness campaign
The comedian and type 2 diabetic is partnering with Genentech to spotlight diabetic macular edema through humor and personal experience.